Kidney cancer treatment depends on the exact tumor type, size and location, whether disease is confined to the kidney or metastatic, kidney function, other medical conditions and previous treatment. German university urology departments publish pathways ranging from kidney-preserving surgery for selected localized tumors to radical surgery, minimally invasive local treatment and systemic oncology for advanced renal cell carcinoma. The correct route should be defined after review of the imaging and complete clinical record rather than by choosing a surgical technique in isolation.
Confirm whether the diagnosis is renal cell carcinoma
A renal mass is not one uniform diagnosis. The German team needs the radiology, pathology when tissue has already been obtained, and the wider staging information. Freiburg publishes CT, MRI, ultrasound and biopsy among its renal-cell-carcinoma diagnostic tools, while Heidelberg integrates urologic tumors within a multidisciplinary cancer-center pathway.
Localized disease may allow kidney-preserving surgery
For selected localized renal tumors, partial nephrectomy can remove the tumor while preserving functioning kidney tissue. Heidelberg describes kidney-preserving surgery and robotic technology for renal tumors, while Freiburg lists partial nephrectomy among its treatment methods. Whether partial nephrectomy is appropriate depends on tumor anatomy, size, location, kidney function and surgical risk.
Radical nephrectomy is a different surgical episode
When kidney-preserving surgery is not appropriate, removal of the affected kidney may be considered. The decision should account for disease extent, the opposite kidney, renal function and the overall oncology plan. Complex tumors can require more extensive multidisciplinary surgery than a standard minimally invasive nephrectomy.
Minimally invasive and robotic surgery are tools, not indications
Heidelberg and Freiburg publish minimally invasive and robotic approaches for renal tumors. A robot-assisted operation can be useful in selected cases, but the priority is achieving the appropriate cancer operation while preserving kidney function when oncologically and technically reasonable. Open surgery may still be appropriate for complex disease.
Ablation can be considered in selected patients
Freiburg publishes radiofrequency ablation and cryotherapy among treatment options for selected renal tumors, including patients who may not be suitable for surgery. These techniques are not interchangeable with surgery for every tumor; size, location, pathology confidence, kidney function and follow-up requirements matter.
Advanced renal cell carcinoma needs systemic oncology review
For advanced or metastatic renal cell carcinoma, Freiburg publishes targeted therapy and immunotherapy, and Heidelberg's current clinical-study portfolio includes immune-checkpoint and targeted-therapy strategies in metastatic RCC. Systemic treatment selection changes over time and depends on histology, risk, prior therapy and disease distribution, so international patients should seek a current specialist review rather than rely on an old regimen list.
Records to send before travelling
A useful urologic-oncology review should allow the German team to determine stage, surgical complexity and kidney-function risk.
- Recent contrast CT or MRI of the abdomen in DICOM format
- Chest imaging and other staging studies when already performed
- Radiology reports with tumor size and location
- Pathology report if biopsy or surgery has already been performed
- Previous operative reports
- Serum creatinine, estimated GFR and relevant laboratory results
- Current medications and major cardiovascular or renal conditions
- Previous systemic cancer treatment if disease is metastatic
- A clear question about partial nephrectomy, radical surgery, ablation, systemic treatment or second opinion
Ask about kidney function as well as cancer control
Surgical planning should consider both oncologic treatment and preservation of renal function. Ask how much kidney tissue is expected to remain, whether nephrology input is needed, which laboratory checks are required after treatment and how kidney function will be monitored after the patient returns home.
Do not book surgery before the German team reviews the images
A treatment request should ideally start with remote review of current CT/MRI and clinical records. The hospital can then decide whether the proposed operation is appropriate, whether additional staging or pathology review is needed and what treatment episode should be included in the estimate before travel is booked.
Sources and review
This guide was last source-reviewed on 2026-08-30.
- Department of Urology – integrated urologic oncology and renal surgery — Heidelberg University Hospital ↗
- Renal cell carcinoma – diagnostics and treatment — University Medical Center Freiburg ↗
- Center for Urogenital Tumors — University Medical Center Freiburg ↗
- Renal tumors – diagnosis and treatment — University Hospital Düsseldorf ↗